Literature DB >> 17589422

Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection.

S Nimmaanrat1, C Prechawai, W Tanomkiat.   

Abstract

AIM: The aim of this study was to analyze anesthetic techniques and complications found in patients with hepatocellular carcinoma (HCC) who have undergone percutaneous ethanol injection (PEI).
METHODS: A retrospective study was performed on 67 patients with HCC who underwent 120 sessions of ultrasound-guided PEI between January 2004 and April 2006.
RESULTS: The mean age of the patients was 56.4 (25-77) years. Males accounted for the majority of the patients (75%). The ASA classifications were from ASA class I (2.5%), class II (82.5%), and class III (15%). Premedication with benzodiazepines was given to 68.3% of the patients. In 81.7% of the procedures, the patients received total intravenous anesthesia with 13.3%, 4.2%, and 0.8% undergoing general anesthesia with either an endotracheal tube, general anesthesia with mask, or monitored anesthesia care, respectively. Most (95.8%) patients were given propofol. Thiopental and ketamine (1.7% each) were used as an induction agent. In only 0.8% of the sessions did the patient receive morphine as an intraprocedural analgesic, while 99.2% of the sessions received fentanyl. Isoflurane was delivered to all of the patients receiving general anesthesia. Bradycardia, hypotension, bradycardia plus hypotension and hypotension plus hypoxemia occurred in 0.8%, 6%, 0.8% and 0.8% of the sessions, respectively. A single patient (1.5% of the patients or 0.8% of the sessions) had cardiovascular collapse during the procedure. The mean duration of anesthesia was 34.7 (10-105) min and the patients were observed in a recovery room for a mean duration of 51.7 (0-175) min. The majority of the recovery room admissions (89.2%) did not have any complications. A minority of the cases (9.2%) received fentanyl in the recovery room as a means of pain management.
CONCLUSION: Various kinds of anesthesia are suitable for patients with HCC scheduled for ultrasound-guided PEI. Although PEI is not commonly associated with serious complications, it is not entirely risk-free and careful monitoring and prompt resuscitation are essential for the safety of the patients as the procedure is performed in an interventional radiology suite, which is considered to be a remote area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589422

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

1.  Percutaneous ethanol ablation of hepatocellular carcinoma: periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment.

Authors:  Kirsteen Rennie Burton; Helena O'Dwyer; Charles Scudamore
Journal:  Can J Gastroenterol       Date:  2009-08       Impact factor: 3.522

2.  Safety and efficacy of pentazocine-midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma.

Authors:  Masanori Nakano; Yuichi Torisu; Chika Nakagawa; Kaoru Ueda; Tomoya Kanai; Chisato Saeki; Tsunekazu Oikawa; Masayuki Saruta
Journal:  JGH Open       Date:  2022-07-17

3.  Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders.

Authors:  Nathan Elie Frenk; Fernando Sebastianes; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Berenice Bilharinho Mendonca; Marcos Roberto de Menezes
Journal:  Clinics (Sao Paulo)       Date:  2016-10-01       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.